Janney Montgomery Scott
XERS icon

Janney Montgomery Scott’s Xeris Biopharma Holdings XERS Stock Holding History

Janney Montgomery Scott’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$200K Hold
25,200
– – ﹤0.01% 2995
2026
Q1 		$146K Buy
25,200
+750
+3% +$4.97K ﹤0.01% 2672
2025
Q4 		$192K Sell
24,450
-1,750
-7% -$13.8K ﹤0.01% 2813
2025
Q3 		$213K Buy
26,200
+1,000
+4% +$6.64K ﹤0.01% 2701
2025
Q2 		$118K Buy
+25,200
New +$115K ﹤0.01% 2635
2025
Q1 		– Sell
-23,000
Closed -$78K – 2887
2024
Q4 		$78K Buy
23,000
+5,500
+31% +$17.7K ﹤0.01% 2644
2024
Q3 		$50K Buy
17,500
+6,750
+63% +$17.3K ﹤0.01% 2617
2024
Q2 		$24K Buy
10,750
+447
+4% +$901 ﹤0.01% 2578
2024
Q1 		$23K Buy
+10,303
New +$26.7K ﹤0.01% 2697

Other funds holding XERS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Janney Montgomery Scott's XERS Position: Q2 2026 in Review

Janney Montgomery Scott held its Xeris Biopharma Holdings (XERS) position steady in Q2 2026 at 25,200 shares worth $200K. The position accounts for ﹤0.01% of the portfolio, ranked #2995.

Janney Montgomery Scott first reported a position in XERS in Q1 2024 and has held it in 9 quarters since. The position peaked at $213K in Q3 2025. 240 funds tracked by Wall St. Rank hold XERS as of Q2 2026.

  • Janney Montgomery Scott held 25,200 shares of Xeris Biopharma Holdings worth $200K as of Q2 2026.
  • Janney Montgomery Scott left its Xeris Biopharma Holdings share count unchanged in Q2 2026.
  • Xeris Biopharma Holdings made up ﹤0.01% of Janney Montgomery Scott's portfolio in Q2 2026, its #2995 holding.
  • Janney Montgomery Scott first reported a position in Xeris Biopharma Holdings in Q1 2024 and has held it in 9 quarters since.
  • Janney Montgomery Scott's Xeris Biopharma Holdings position peaked at $213K in Q3 2025.
  • 240 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2026.

Based on Janney Montgomery Scott's 13F filing for Q2 2026, filed 5 Aug 2026.